Similar articles

• Thyroid dysfunction in antiviral therapy of chronic hepatitis C.

  Dabrowska MM, Panasiuk A, Flisiak R. Dabrowska MM, et al. Hepatogastroenterology. 2010 Jul-Aug;57(101):826-31. Hepatogastroenterology. 2010. PMID: 21033237
• [Eradication of hepatitis C virus after 3 months of interferon treatment in a patient with chronic hepatitis C].

  Winkfield B, Lunel F, Beurrier P, Calès P. Winkfield B, et al. Gastroenterol Clin Biol. 2000 Jan;24(1):136-7. Gastroenterol Clin Biol. 2000. PMID: 10755865 French. No abstract available.
• [Chronic hepatitis C, autoimmunity and interferon alfa treatment].

  Garcia Buey L, Moreno Otero R. Garcia Buey L, et al. Rev Esp Enferm Dig. 1999 Mar;91(3):165-7. Rev Esp Enferm Dig. 1999. PMID: 10348601 Review. Spanish. No abstract available.
• [Serum intercellular adhesion molecule ICAM-1 concentration in interferon alpha treated patients with chronic viral C hepatitis].

  Warakomska I, Wiczkowski A, Kepa L, Stolarz W, Wilczek K, Błedowski D, Sobala-Szczygieł B, Oczko-Grzesik B, Dziambor AP, Mossor K. Warakomska I, et al. Wiad Lek. 2004;57(11-12):641-6. Wiad Lek. 2004. PMID: 15865242 Polish.
• Host factors and failure of interferon-alpha treatment in hepatitis C virus.

  Gao B, Hong F, Radaeva S. Gao B, et al. Hepatology. 2004 Apr;39(4):880-90. doi: 10.1002/hep.20139. Hepatology. 2004. PMID: 15057887 Review.